Martina Pigazzi Selected Research

Martina Pigazzi Research Topics

Disease

14	Leukemia 12/2023 - 05/2006
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 03/2009
12	Neoplasms (Cancer) 04/2024 - 07/2009
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 12/2011
2	Residual Neoplasm 01/2024 - 03/2015
2	Myeloid Leukemia (Leukemia, Myelocytic) 02/2011 - 01/2009
1	Hepatoblastoma 01/2024
1	Chronic Granulomatous Disease 11/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2020
1	monosomy Chromosome 7 01/2016
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2015
1	Sarcoma (Soft Tissue Sarcoma) 07/2014
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 07/2009
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 05/2006

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
3	Long Noncoding RNAIBA 11/2021 - 05/2015
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2022
2	CytokinesIBA 01/2024 - 01/2021
2	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2009
2	Messenger RNA (mRNA)IBA 04/2017 - 04/2016
2	Carrier Proteins (Binding Protein)IBA 04/2016 - 03/2009
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 02/2011 - 10/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2023
1	AntigensIBA 12/2023
1	Tigecycline (Tygacil)FDA Link 11/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2021
1	venetoclaxIBA 01/2021
1	lercanidipineIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Vincristine (Oncovin)FDA LinkGeneric 06/2020
1	BI D1870IBA 06/2020
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 06/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 04/2017
1	Insulin-Like PeptidesIBA 04/2016
1	nuclear pore complex protein 98IBA 01/2016
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2016
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Guanosine Triphosphate (GTP)IBA 07/2014
1	Core Binding Factors (Core-Binding Factor)IBA 07/2013
1	DNA Methyltransferase 3AIBA 12/2011
1	Adenosine Monophosphate (AMP)IBA 02/2011
1	Apoptosis Regulatory ProteinsIBA 01/2011
1	alvocidib (flavopiridol)IBA 07/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2009
1	Anaplastic Lymphoma KinaseIBA 07/2009
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2009
1	Phosphotransferases (Kinase)IBA 07/2009
1	ElementsIBA 03/2009
1	Cyclic AMP (AMP, Cyclic)IBA 03/2009

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2021 - 07/2009
3	Therapeutics 04/2024 - 03/2015
3	Hematopoietic Stem Cell Transplantation 11/2023 - 01/2020
1	Hepatectomy 01/2024
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2006